The key rheumatology question, however, is why some people with conditions such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and osteoarthritis are reporting symptom improvements while taking them
Clinically, this often surfaces as cognitive fatigue, difficulty with memory retrieval, and the phenomenon that many women describe as "menofog," a pervasive sense of mental cloudiness that is not simply tiredness but reflects a genuine disruption in how brain cells are producing and managing energy [2]
C.NucciM
Therapeutic strategies targeting SQOR must therefore be calibrated to the disease context
kantsz ekilde "bilim yle diyor." demekle olmaz
In a study published in the New England Journal of Medicine, participants who received semaglutide experienced an average weight loss of 14.9% of their initial body weight over 68 weeks